![]() |
市場調查報告書
商品編碼
1384977
全球兒科灌注市場規模、佔有率、行業趨勢分析報告:2023-2030 年依最終用途、產品和地區分類的展望和預測Global Pediatric Perfusion Market Size, Share & Industry Trends Analysis Report By End-use (Hospitals, Cardiac Centers, and Others), By Product, By Regional Outlook and Forecast, 2023 - 2030 |
預計到 2030 年,兒科灌注市場規模將達到 8.018 億美元,預測期內CAGR年成長率為 5.8%。
然而,缺乏醫療資源和人員,例如兒科灌注師和專業灌注設備,也對可近性產生了不利影響。在資源有限的地區,兒童心血管手術和灌注服務的預約次數可能較少,等待時間較長。這不僅影響治療質量,還會增加家庭的壓力和焦慮。此外,缺乏專業資源將給醫療保健提供者帶來負擔,進一步阻礙市場成長潛力。
此外,大流行造成的醫療資源緊張,例如為 COVID-19 護理分配人員和設備,也對非 COVID 相關的醫療保健產生了負面影響,包括兒童心臟護理。一些兒童心血管手術和程序被推遲或重新安排,影響了灌注師的時間表和工作量。由於擔心病毒傳播和門鎖措施,一些醫療機構在大流行期間的患者人數下降。患者數量的減少導致對這些服務和設備的需求減少。
最終用途展望
根據最終用途,市場分為醫院、心臟中心等。在2022年的市場中,心臟中心部門佔很大的收益佔有率。心臟中心通常會聘請高度專業化的兒科灌注專家,他們在管理年輕患者的獨特需求方面擁有豐富的經驗。這些專業人員了解兒童心血管手術的複雜性,因此有能力處理兒童心血管手術期間灌注的細微差別。心臟中心配備了最先進的灌注設備,旨在滿足兒童患者的獨特需求。這包括適合兒童的專用氧合器、插管和監測系統。
產品展望
市場依產品區隔為兒童用氧合器、兒童用插管、兒童用血液幫浦、兒童用動脈過濾器、監測系統等。監控系統部門在 2022 年獲得了可喜的市場成長率。兒科灌注監測系統領域透過優先考慮患者安全並利用技術進步在心血管手術期間提供即時資料和回饋來推動成長。該領域的成長是由於心血管手術數量的增加、監管標準的遵守以及持續監測的需求不斷增加。
區域展望
從區域來看,本報告對北美、歐洲、亞太地區和拉丁美洲地區的市場進行了分析。 2022年亞太地區將出現顯著的市場成長率。心血管疾病的高盛行率和先進的醫療基礎設施是促成這一成長的因素。由於該地區政府採取了多項舉措,預計該市場也將成長。大量的研發投資、鼓勵性的政府政策以及公眾對 CPB 設備認知的提高正在促進市場的成長。這些因素增加了 CPB 設備的需求和採用,推動了該地區的整體市場成長。
The Global Pediatric Perfusion Market size is expected to reach $801.8 million by 2030, rising at a market growth of 5.8% CAGR during the forecast period.
The Children's Hospital Graduate Medical Education (CHGME) Program and National Congenital Heart Disease Action Plan have aided in increasing the awareness of CHD in newborns. Therefore, Hospitals segment generated $3,95.1 million revenue in the market in 2022. As a result, the CHGME program also provides federal funding to children's hospitals for graduate medical education. It supports the training of pediatric perfusionists and healthcare professionals specializing in pediatric cardiac care. Some of the factors impacting the market are rising R&D and multidisciplinary approach towards patient care, increasing incidence of congenital heart defects and limited accessibility to specialized care.
The positive impact of a multidisciplinary approach is further complemented by ongoing research and development in the field. Research initiatives aim to explore new techniques, technologies, and best practices that can enhance the safety and efficacy of pediatric perfusion. These efforts have led to the creation of more advanced and efficient perfusion equipment and techniques, driving further growth in the market. Additionally, CHDs are structural heart abnormalities that are present at birth and often require surgical intervention, making pediatric perfusion services a crucial component of the care provided to these young patients. According to the National Library of Medicine, the birth prevalence of CHD varies among studies worldwide and is mostly reported between 8 and 12 per 1000. Therefore, all these aforementioned factors will aid in the expansion of the market in the coming years and the combined effect of these factors has transformed the landscape of pediatric cardiac care, with pediatric perfusionists playing a central role in ensuring the well-being of children with congenital heart defects.
However, the scarcity of healthcare resources and personnel, such as pediatric perfusionists and specialized perfusion equipment, also plays a detrimental role in accessibility. In regions with limited resources, there may be fewer available appointments for pediatric cardiac surgeries and perfusion services, leading to prolonged wait times. This not only affects the quality of care but also increases stress and uncertainty for families. Moreover, the shortage of specialized resources can place a strain on healthcare providers, further hampering the market's growth potential.
Additionally, the strain on healthcare resources due to the pandemic, such as the allocation of staff and equipment to COVID-19 care, had negative implications for non-COVID-related healthcare, including pediatric cardiac care. Some pediatric cardiac surgeries and procedures were delayed or rescheduled, impacting the scheduling and workloads of perfusionists. Some healthcare facilities experienced a reduction in patient volumes during the pandemic due to concerns about virus transmission and lockdown measures. This reduced patient volume led to decreased demand for these services and equipment.
End Use Outlook
On the basis of end-use, the market is segmented into hospitals, cardiac centers, and others. The cardiac centers segment witnessed a significant revenue share in the market in 2022. Cardiac centers typically employ highly specialized pediatric perfusionists who have extensive experience in managing the unique needs of young patients. These professionals understand the complexities of pediatric cardiac surgery, making them well-equipped to handle the nuances of perfusion during these procedures. Cardiac centers are equipped with state-of-the-art perfusion equipment designed to cater to the unique needs of pediatric patients. This includes specialized oxygenators, cannulae, and monitoring systems suitable for children.
Product Outlook
Based on product, the market is divided into pediatric oxygenators, pediatric cannulae, pediatric blood pumps, pediatric arterial filters, monitoring systems, and others. The monitoring systems segment procured a promising growth rate in the market in 2022. By prioritizing patient safety and taking advantage of technological advancements, the pediatric perfusion monitoring systems segment drives growth by offering real-time data along with feedback during cardiac surgeries. The segment's growth is attributed to the growing number of heart surgeries, regulatory standard compliance, and the growing need for continuous monitoring.
Regional Outlook
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific region procured a remarkable growth rate in the market in 2022. High CVD prevalence and an advanced healthcare infrastructure are responsible for this growth. The market is also expected to grow as a result of several government initiatives in this region. Significant R&D investments, encouraging government policies, and rising public awareness of CPB machines contribute to the market's growth. Owing to these factors, there is a growing need for and adoption of CPB machines, which propels the regional market's overall growth.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, LivaNova PLC, Terumo Corporation, BL Lifesciences (BL group of family companies), Cardinal Health, Inc., EUROSETS S.R.L. (GVM Care Research), Getinge AB, Koninklijke Philips N.V., Nonin Medical, Inc. and GE HealthCare Technologies, Inc.
Strategies Deployed in Pediatric Perfusion Market
Aug-2023: Medtronic PLC came into partnership with Cydar Medical, a UK-based medical Equipment Manufacturing company. Through this partnership, Medtronic PLC would focus on bolstering exceptional service and assistance to healthcare professionals, ensuring the validation of long-term predictive abilities, and advancing patient care.
Feb-2023: Koninklijke Philips N.V. came into partnership with TriHealth, a unified health system based in Cincinnati, Ohio, United States. Through this partnership, TriHealth would enhance its cardiac care services and fulfill its commitment to the local community, by offering top-notch healthcare, working in the best interests of the community, collaborating with physicians and other healthcare providers to streamline health services, and contributing to the education of future healthcare professionals.
Aug-2022: Medtronic PLC came into partnership with BioIntelliSense, a US-based medical device company. This partnership would enable Medtronic's Patient Monitoring division to offer a medical-grade device that will provide ongoing vital sign monitoring for patients receiving general care within the hospital and after discharge.
Oct-2021: Koninklijke Philips N.V. unveiled a comprehensive solution called "Philips Pediatric Coaching," which aims to create a more relaxed and comfortable experience for parents and their children who are going through MRI scans.
Sep-2021: Terumo Corporation came into partnership with Etiometry, a US-based Hospital and Health Care company. Through this partnership, Terumo Corporation would aim to provide state-of-the-art clinical decision support for adults undergoing cardiac surgery, both during the surgical procedure and throughout their post-surgery recovery period.
Mar-2021: Koninklijke Philips N.V. came into Partnership with DiA Imaging Analysis Ltd, a hospital and Healthcare company. Through this partnership, Koninklijke Philips N.V. would provide an unmatched level of diagnostic certainty and streamline operational effectiveness in point-of-care ultrasound imaging. Additionally, this partnership also extends the reach of superior and timely healthcare, both within and beyond hospital settings.
Feb-2021: Terumo Corporation took over Health Outcomes Sciences, Inc. (HOS), a Pharmaceutical Manufacturing company. Through this acquisition, Terumo Corporation would focus on Expanding its footprint in the digital healthcare sector offers a promising avenue for the company's growth.
Market Segments covered in the Report:
By End Use
By Product
By Geography
Companies Profiled
Unique Offerings from KBV Research